Sponsor pipeline

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) clinical trial pipeline

3 active trials 2 recruiting 4 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-09-22	NCT07833631 A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in…		Completed

Phase 1/2		1
Phase 2		2

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT06965621	18F-mFBG Imaging for Myocardial Sympathetic Innervation	Heart Failure	Recruiting	2026-07-01
NCT07176286	18F-mFBG Cardiac Uptake With Lewy Body Dementia	Parkinson Disease (PD)	Recruiting	2026-07-01
Phase 1/2
NCT04535193	Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation	Cardiovascular Diseases	Active, Not Recruiting	2026-07-02

Get alerts when Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.